These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24076648)

  • 1. [Updates on rickets and osteomalacia: the therapy for FGF23 related rickets].
    Yamamoto T
    Clin Calcium; 2013 Oct; 23(10):1491-6. PubMed ID: 24076648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rickets guidance: part II-management.
    Haffner D; Leifheit-Nestler M; Grund A; Schnabel D
    Pediatr Nephrol; 2022 Oct; 37(10):2289-2302. PubMed ID: 35352187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rickets/Osteomalacia. Anti-FGF23 antibody therapy in patients with FGF23-related hypophosphatemic rickets and osteomalacia.].
    Kinoshita Y
    Clin Calcium; 2018; 28(10):1373-1379. PubMed ID: 30269120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A patient with hypophosphatemic rickets and ossification of posterior longitudinal ligament caused by a novel homozygous mutation in ENPP1 gene.
    Saito T; Shimizu Y; Hori M; Taguchi M; Igarashi T; Fukumoto S; Fujitab T
    Bone; 2011 Oct; 49(4):913-6. PubMed ID: 21745613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Updates on rickets and osteomalacia: anti-FGF23 antibody, a new therapeutic approach for hypophosphatemic rickets/osteomalacia].
    Shimada T
    Clin Calcium; 2013 Oct; 23(10):1469-75. PubMed ID: 24076645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF23 and disorders of phosphate homeostasis.
    Yu X; White KE
    Cytokine Growth Factor Rev; 2005 Apr; 16(2):221-32. PubMed ID: 15863037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulation and disorders of calcium and phosphate metabolism].
    Michigami T
    Clin Calcium; 2014 Feb; 24(2):169-75. PubMed ID: 24473349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Updates on rickets and osteomalacia: FGF23-mediated hypophosphatemic rickets/osteomalacia].
    Michigami T
    Clin Calcium; 2013 Oct; 23(10):1429-35. PubMed ID: 24076640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
    Larsson T; Marsell R; Schipani E; Ohlsson C; Ljunggren O; Tenenhouse HS; Jüppner H; Jonsson KB
    Endocrinology; 2004 Jul; 145(7):3087-94. PubMed ID: 14988389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Updates on rickets and osteomalacia: various roles of Klotho and FGF23 in vivo ].
    Imura A
    Clin Calcium; 2013 Oct; 23(10):1476-82. PubMed ID: 24076646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FGF23 and bone metabolism].
    Ito N; Fukumoto S
    Clin Calcium; 2005 Jul; 15(7):43-8. PubMed ID: 15995295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 (FGF23) and the kidney.
    Tsagalis G; Psimenou E; Manios E; Laggouranis A
    Int J Artif Organs; 2009 Apr; 32(4):232-9. PubMed ID: 19569031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxyvitamin D Alone Improves Skeletal Growth, Microarchitecture, and Strength in a Murine Model of XLH, Despite Enhanced FGF23 Expression.
    Liu ES; Martins JS; Raimann A; Chae BT; Brooks DJ; Jorgetti V; Bouxsein ML; Demay MB
    J Bone Miner Res; 2016 May; 31(5):929-39. PubMed ID: 26751835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.
    Bai X; Miao D; Li J; Goltzman D; Karaplis AC
    Endocrinology; 2004 Nov; 145(11):5269-79. PubMed ID: 15284207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rickets/Osteomalacia. Action of FGF23.].
    Inoue D
    Clin Calcium; 2018; 28(10):1335-1342. PubMed ID: 30269115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
    Goldsweig BK; Carpenter TO
    Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.
    Imel EA; Hui SL; Econs MJ
    J Bone Miner Res; 2007 Apr; 22(4):520-6. PubMed ID: 17227222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases].
    Fukumoto S
    Clin Calcium; 2015 Jan; 25(1):37-44. PubMed ID: 25530521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.